Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | APP | P05067 | 1/20 | 0.31 |
| ▸ | SNCA | P37840 | 1/20 | 0.31 |
| ▸ | KRAS | P01116 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2187769 | 0.75 | CYP1A2 (0.54) | CYP1A2APPSNCA | |
| SCHEMBL2187774 | 0.75 | CYP1A2 (0.54) | CYP1A2APPSNCA | |
| SCHEMBL10851929 | 0.71 | CYP1A2 (0.33) | CYP1A2APPSNCA | |
| SCHEMBL2491578 | 0.71 | CYP1A2 (0.37) | CYP1A2APPSNCA | |
| SCHEMBL28235472 | 0.68 | APP (0.36) | CYP1A2APPSNCA | |
| SCHEMBL19652495 | 0.68 | CYP1A2 (0.50) | CYP1A2APPSNCA | |
| SCHEMBL19652487 | 0.67 | CYP1A2 (0.49) | CYP1A2APPSNCA | |
| SCHEMBL19652491 | 0.67 | CYP1A2 (0.49) | CYP1A2APPSNCA | |
| SCHEMBL11703479 | 0.66 | CYP1A2 (0.51) | CYP1A2APPSNCA | |
| SCHEMBL4495310 | 0.64 | CYP1A2 (0.44) | CYP1A2APPSNCA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | claimed |
| US-8673272-B2 | Ultraviolet-absorbing compounds | ISP INVESTMENTS INC. (US) | 2014-03-18 | — | — | US | disclosed |
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | AVOCA LLC | 2011-01-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110020251-A1 | Ultraviolet-Absorbing Compounds | UFM1, UHRF1, CUTA | CYP1A2 937/4885APP 325/4885SNCA 3396/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.